Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Renal Insufficiency, Chronic D051436 9 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Carcinogenesis D063646 3 associated lipids
Rickets, Hypophosphatemic D063730 1 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Michaud L et al. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. 2002 Clin Nutr pmid:12381338
Oldham FB Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable? 2002 Am. J. Kidney Dis. pmid:12407662
Silverberg DS et al. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. 2002 Clin. Nephrol. pmid:12227725
Hosoya S et al. Identification and characterization of the Bacillus subtilis D-glucarate/galactarate utilization operon ycbCDEFGHJ. 2002 FEMS Microbiol. Lett. pmid:12044674
Boase S and Miners JO In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. 2002 Br J Clin Pharmacol pmid:12445028
Hörl WH Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 Sep-Oct Perit Dial Int pmid:11757843
Prakash S et al. Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 May-Jun Perit Dial Int pmid:11475345
Chandler G et al. Intravenous iron sucrose: establishing a safe dose. 2001 Am. J. Kidney Dis. pmid:11684551
Stoves J et al. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. 2001 Nephrol. Dial. Transplant. pmid:11328902
Pach J et al. New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity. 2001 Prz. Lek. pmid:11450331
Breymann C et al. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. 2001 Am. J. Obstet. Gynecol. pmid:11262469
Pollak A et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. 2001 Pediatrics pmid:11134438
Charytan C et al. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. 2001 Am. J. Kidney Dis. pmid:11157370
Kosch M and Schaefer RM [Iron deficiency. When parenteral substitution?]. 2001 MMW Fortschr Med pmid:11247361
Merbouh N et al. Facile nitroxide-mediated oxidations of D-glucose to D-glucaric acid. 2001 Carbohydr. Res. pmid:11675028
Kaltwasser JP et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. 2001 J. Rheumatol. pmid:11708414
Duffy CI Iron sucrose or ferric gluconate? 2001 Am. J. Kidney Dis. pmid:11728988
Gasche C et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. 2001 Am. J. Gastroenterol. pmid:11513178
Fishbane S and Kowalski EA The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. 2000 Nov-Dec Semin Dial pmid:11130261
Johnson LL et al. Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. 2000 Nov-Dec J Nucl Cardiol pmid:11144474
Yoshimi N et al. Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. 2000 Int. J. Oncol. pmid:10601547
Bailie GR et al. Parenteral iron use in the management of anemia in end-stage renal disease patients. 2000 Am. J. Kidney Dis. pmid:10620537
Descombes E and Fellay G Improved response to erythropoietin therapy with long-term continuous iron supplementation. 2000 Nephron pmid:10657727
Fujita K et al. Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1). 2000 Life Sci. pmid:10821120
Wiersema AM et al. Early assessment of skeletal muscle damage after ischaemia-reperfusion injury using Tc-99m-glucarate. 2000 Cardiovasc Surg pmid:10799826
Fujii Y et al. Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001). 2000 Biomed. Pharmacother. pmid:10759292
Gulick AM et al. Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. 2000 Biochemistry pmid:10769114
Wargovich MJ et al. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. 2000 Carcinogenesis pmid:10837003
Parkkinen J et al. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. 2000 Nephrol. Dial. Transplant. pmid:11071973
Kao HH et al. Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy. 2000 Chang Gung Med J pmid:11126152
van Iperen CE et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. 2000 Crit. Care Med. pmid:10966249
Krafft A et al. Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. 2000 Acta Obstet Gynecol Scand pmid:10949245
Gombotz H et al. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. 2000 Acta Anaesthesiol Scand pmid:10903019
Van Wyck DB et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. 2000 Am. J. Kidney Dis. pmid:10873877
Monterrubio R et al. A common regulator for the operons encoding the enzymes involved in D-galactarate, D-glucarate, and D-glycerate utilization in Escherichia coli. 2000 J. Bacteriol. pmid:10762278
Lubberink M et al. Quantification aspects of patient studies with 52Fe in positron emission tomography. 1999 Appl Radiat Isot pmid:10581681
Braun L et al. Different induction of gulonolactone oxidase in aromatic hydrocarbon-responsive or -unresponsive mouse strains. 1999 FEBS Lett. pmid:10606751
Mariani G et al. Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. 1999 J. Nucl. Med. pmid:10565778
Jahn M et al. The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. 1999 Carbohydr. Res. pmid:10614067
Weisbach V et al. Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study. 1999 Transfusion pmid:10335995
Nakatsugawa S et al. Inhibitory effect of ND2001 on spontaneous multiple metastasis of NC 65 tumors derived from human renal cancer cells intradermally transplanted into nude mice. 1999 Anticancer Drugs pmid:10211554
Picaud JC et al. [Iron supplementation in preterm infants treated with erythropoietin]. 1999 Arch Pediatr pmid:10394459
Krafft A et al. Erythropoietic quality of maternal milk. 1999 Lancet pmid:10475225
Lim PS et al. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. 1999 Nephrol. Dial. Transplant. pmid:10534512
Gasche C et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. 1999 Digestion pmid:10343140
Edelson SB and Cantor DS Autism: xenobiotic influences. 1998 Nov-Dec Toxicol Ind Health pmid:9891912
Hubbard BK et al. Evolution of enzymatic activities in the enolase superfamily: characterization of the (D)-glucarate/galactarate catabolic pathway in Escherichia coli. 1998 Biochemistry pmid:9772162
Kuramitsu Y et al. A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward laminin. 1998 Anticancer Drugs pmid:9491797
Nonaka D et al. Gelatinous bone marrow transformation complicated by self-induced malnutrition. 1998 Acta Haematol. pmid:9792939
Hong SK and Rankin GO Biotransformation of 2-chloroaniline in the Fischer 344 rat: identification of urinary metabolites. 1998 Xenobiotica pmid:9849645